Transfer Of Value Disclosure

FINANCIAL INFORMATION:

The following describes the funding received from non-NHS organisations to support programmes of work that aim to improve the health and care system in  the North East and North Cumbria:

Organisations Involved Start Date End Date Monetary Value Reason for Benefit
Chiesi Farmaceutici and AHSN NENC 01/02/2022 16/05/2022 £5,000.00 To develop the Pharm outcomes template for the Tees Valley Inhaler Project
OrionPharma (UK) Ltd and AHSN NENC 01/02/2022 16/05/2022 £5,400.00 To develop the Pharm outcomes template for the Tees Valley Inhaler Project
AstraZeneca PLC and AHSN NENC 01/02/2022 16/05/2022 £26,400.00 To deliver the pilot programme of work for the Tees Valley Inhaler project
GlaxoSmithKline and AHSN NENC 01/02/2022 16/05/2022 £5,400.00 To develop the Pharm outcomes template as part of the Tees Valley Inhaler project
Sanofi 31/03/2022 30/09/2023 £37,479.28 JWA to facilitate earlier diagnosis of Fabry, Pompe and Gaucher diseases through the use of disease prediction models using real-work data from Primary Care records (CDRC – rare diseases)
Sanofi 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Amgen Ltd 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Novartis Pharmaceuticals UK Ltd 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Daiichi Sankyo 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Amarin UK Ltd 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Sanofi (registered name Aventis Pharma Ltd) 18/11/2022 31/03/2023 £768.00 Reimbursement costs for a guest speaker at a Sanofi event
Novartis Pharmaceuticals 23/12/2022 23/12/2023 £150,000 Undertake medical education activities around holistic lipid management and prevention of CVD
Boehringer Ingleheim 01/02/2022 30/09/2023 3000 Contracts Grant/donation towards education and service development in support of Improving outcomes for Respiratory patients, Tees Valley inhaler project
Novartis Pharmaceuticals UK Limited 20/10/2021 31/03/2024 £111,294 Support the implementation of the NHSE-Novartis collaboration project as part of the AHSN Network’s national lipid optimisation programme
Novartis Pharmaceuticals UK Limited 01/04/2023 31/03/2024 £198,000 Sustain secondary care and primary care clinical roles, develop primary care lipid hub and embed projects supported by AHSN NENC CVD team
Novartis Pharmaceuticals UK Limited 27/09/2022 26/04/2024 £135,024 Promote the use of the nationally endorsed lipid management pathway and service transformation work and promote adoption of best practice
Amarin UK Limited 17/07/2023 19/10/2023 £650 To support the annual Northern Lipid Forum
Amarin UK Limited, South Tyneside and Sunderland NHS FT and AHSN NENC 01/10/2023 30/09/2024 £38,200 The project is to secure and expand the Lipid Optimisation clinic at STSFT and take a holistic approach to patient care, including provision of dietician support for patients.
Daiichi Sankyo 15/06/2023 30/11/2024 £650 To support the annual Northern Lipid Forum
Amgen 16/06/2023 30/11/2024 £650 To support the annual Northern Lipid Forum